Weight Loss Wars Intensify as Novo sues to keep copycats off shelves

Описание: Bloomberg News Health Reporter Madison Muller reports on the latest on Novo's lawsuit. - Novo Nordisk said it’s suing Hims & Hers Health Inc. for making knock-offs of its obesity medicines, even as Hims scrapped plans to sell a copycat version of the Wegovy pill. Hims is breaching the US patent on semaglutide, the active ingredient in Novo’s blockbuster obesity treatments, Novo argued Monday. The US lawsuit attacks not only Hims’ new strategy to launch a copycat pill but also goes after shots that mimic Wegovy and its sister drug Ozempic.
The move marks a more aggressive approach for Novo under Chief Executive Officer Mike Doustdar. Until now, the drugmaker’s legal strategy focused on the way that companies like Hims market their products. Novo said this is the first time it has sued over patent infringement for compounded semaglutide.
--------
More on Bloomberg Television and Markets

Like this video? Subscribe and turn on notifications so you don't miss any videos from Bloomberg Markets & Finance: https://tinyurl.com/ysu5b8a9
Visit http://www.bloomberg.com for business news & analysis, up-to-the-minute market data, features, profiles and more.

Connect with Bloomberg Television on:
X:   / bloombergtv  
Facebook:   / bloombergtelevision  
Instagram:   / bloombergtv  

Connect with Bloomberg Business on:
X:   / business  
Facebook:   / bloombergbusiness  
Instagram:   / bloombergbusiness  
TikTok: https://www.tiktok.com/@bloombergbusi...
Reddit:   / bloomberg  
LinkedIn:   / bloomberg-news  

More from Bloomberg:
Bloomberg Radio:   / bloombergradio  

Bloomberg Surveillance:   / bsurveillance  
Bloomberg Politics:   / bpolitics  
Bloomberg Originals:   / bbgoriginals  

Watch more on YouTube:
Bloomberg Technology:    / @bloombergtechnology  
Bloomberg Originals:    / @business  
Bloomberg Quicktake:    / @bloombergquicktake  
Bloomberg Espanol:    / @bloomberg_espanol  
Bloomberg Podcasts:    / @bloombergpodcasts